Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Covid"

25 mentions found

FILE PHOTO: An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021. REUTERS/Mike Segar/File Photo(Reuters) -Eli Lilly and Co raised its full-year profit and revenue forecasts on Tuesday, mainly due to higher sales of its COVID-19 antibody therapies, and the drugmaker said it has initiated a rolling submission for its experimental Alzheimer’s treatment. Demand for Lilly’s COVID-19 antibody therapies, bamlanivimab and etesevimab, rose during the last three months as the spread of the Delta variant fueled a sharp rise in infections and hospitalizations in areas with low vaccination rates. The antibody treatments brought in $217 million in the third quarter, up from $149 million in the second quarter. Excluding one-off items, Eli Lilly earned $1.94 per share, missing analyst estimates of $1.98 per share, on higher research and development expenses including for the COVID-19 drugs.
Persons: Eli Lilly, Mike Segar, Lilly Organizations: Company, REUTERS Locations: Branchburg , New Jersey, U.S
Stocks in Indonesia, India Thailand, Singapore and Philippines were up between 0.2% and 0.9%. Malaysian stocks fell 0.2%, dragged by the world's biggest latex glove maker Top Glove and peer Hartalega Holdings. Top Glove and Hartalega fell 1.5% and 4.5%, respectively, after Supermax Corp warned of a hit from a U.S. import ban. Supermax, which is not part of the benchmark stock index, slid 1.6%. Other Asian currencies were mixed against a steady dollar, with the Malaysian ringgit and Taiwan's dollar firming up to 0.2% each, while the Philippine peso slipped.
Persons: Indranil Sarkar, Alvin Tan, Korea's KOSPI, Subhranshu Sahu Organizations: RBC Capital Markets, Asia FX, Bank of, Hartalega Holdings, Supermax Corp, United, Malaysian, Singapore, Keppel Corp, United States Locations: Malaysia, China, Stocks, Indonesia, India Thailand, Singapore, Philippines, Beijing, COVID, Shanghai, Asia, Bank of Korea, Malaysian, U.S, United States, Philippine, United, United States Asia, Japan, Taiwan, Thailand, Bengaluru
Taiwan seen growing 4% in Q3 on pandemic hit, but exports help
  + stars: | 2021-10-26 | by ( )   time to read: +3 min
read moreThat would be its slowest rate of growth since logging 5.09% in the fourth quarter of last year. The outbreak has now ended, and the government has been issuing shopping coupons to help restore consumer confidence. read moreEconomists' forecasts for preliminary GDP data due on Friday varied widely from growth of 2.5% to as high as 6.5%. Kevin Wang, an economist at Taishin Securities Investment Advisory Co, said the drop-off in growth was because of the impact on consumption from the COVID-19 outbreak at home. The International Monetary Fund this month raised its prediction for Taiwan's 2021 growth to 5.9% from 4.7% seen in April.
Persons: Kevin Wang, Carol Lee, Jeanny Kao, Ben Blanchard, Jane Wardell Organizations: Gross, Apple Inc, Taishin Securities Investment Advisory, Taiwan Semiconductor Manufacturing Co, Exports, Monetary Fund, Thomson Locations: TAIPEI, COVID, China
Resume SubscriptionWe are delighted that you'd like to resume your subscription. You will be charged $ + tax (if applicable) for The Wall Street Journal. You may change your billing preferences at any time in the Customer Center or call Customer Service. You will be notified in advance of any changes in rate or terms. You may cancel your subscription at anytime by calling Customer Service.
Organizations: Wall Street
Medical staff prepare Moderna coronavirus (COVID-19) vaccine to be administered at newly-opened mass vaccination centre in Tokyo, Japan, May 24, 2021. Getting access to Moderna vaccines adds diversity to the AU's vaccine supply with different storage requirements. "We are grateful to have helped negotiate this encouraging step forward between Moderna and the African Union that will significantly expand access to vaccines on the continent in the near-term," Quillian said. "This is the first step in our long-term partnership with the African Union," Moderna Chief Executive Stéphane Bancel said in a statement, referring to a Memorandum of Understanding to make up to 110 million doses for the AU. Last month, the AU accused COVID-19 vaccine manufacturers of denying African countries a fair chance to buy vaccines and urged manufacturing countries, in particular India, to lift export restrictions on vaccines and their components.
Persons: Carl Court, Masiyiwa, Biden, Natalie Quillian, Quillian, Moderna, Stéphane Bancel, COVID, Jeff Mason, Robert Birsel Organizations: Moderna, REUTERS, African Union, Moderna Inc, White, Reuters, ., AU, African, Thomson Locations: Tokyo, Japan, REUTERS WASHINGTON, United States, Africa, Moderna, African Union, COVID, India
China urges faster COVID-19 testing amid latest outbreak
  + stars: | 2021-10-26 | by ( )   time to read: +2 min
Frequent testing, and sometimes mass testing, is standard practice in China's containment of domestically transmitted outbreaks in the past year, but health authorities say testing services remain unsatisfactory in parts of China amid flare-ups. China is facing a new wave of infections involving nearly 200 locally transmitted symptomatic cases in 12 provincial areas since Oct. 17. Many of the infected were from remote parts of northwest China without as much health resources as major cities. While China is yet to approve self-testing kits for diagnosing COVID-19, swab tests that require professional labs to process samples are widely available. Local governments have recently cut prices of swab tests, with certain tests charging as little as 13 yuan ($2.00) in the Chinese capital of Beijing.
Persons: Roxanne Liu, Ryan Woo, Gabriel Crossley, Christopher Cushing, Michael Perry Organizations: cnsphoto, REUTERS, National Health Commission, NHC, Thomson Locations: Lanzhou, Gansu province, China, REUTERS BEIJING, Beijing, Inner Mongolia, Zhangjiajie, Yangzhou
Passengers from Amsterdam arrive at Changi Airport under Singapore’s expanded Vaccinated Travel Lane (VTL) quarantine-free travel scheme as the city-state opens its borders to more countries amidst the coronavirus disease (COVID-19) pandemic, in Singapore October 20, 2021. REUTERS/Edgar SuSINGAPORE, Oct 26 (Reuters) - Singapore will allow quarantine-free entry to travellers vaccinated against COVID-19 from Australia and Switzerland from Nov. 8, the city-state's aviation regulator said on Tuesday. Singapore is slowly re-opening its borders and has expanded quarantine-free travel to nearly a dozen countries, including Germany, Canada, France, Britain and the United States, under its Vaccinated Travel Lanes (VTL) programme. Visitors can travel to Singapore under the programme if they have been fully vaccinated and tested negative in COVID-19 tests. Last week, the United States advised citizens against travel to Singapore and raised its alert for the city-state to its highest risk level.
Persons: Edgar Su SINGAPORE, Chen Lin, James Pearson Organizations: Changi Airport, Singapore’s, REUTERS, COVID, Thomson Locations: Amsterdam, Singapore, Australia, Switzerland, Germany, Canada, France, Britain, United States, COVID
Beijing Marathon postponed indefinitely due to COVID-19
  + stars: | 2021-10-26 | by ( )   time to read: +1 min
People wearing face masks cross a street in Beijing, following outbreaks of the coronavirus disease (COVID-19) in China, October 25, 2021. REUTERS/Thomas PeterOct 26 (Reuters) - The Beijing Marathon has been postponed indefinitely after Sunday's race was called off amid rising COVID-19 cases in China, the BBC quoted organisers as saying. The marathon was set to return this year after it was suspended in 2020 due to COVID-19. The Wuhan Marathon, which was due to be held last Sunday, was also called off with a new date yet to be determined. China reported 43 new COVID-19 cases on Monday, up from 39 cases a day earlier, the country's national health authority said on Tuesday.
Persons: Thomas Peter, Manasi Pathak, Peter Rutherford Organizations: REUTERS, Beijing, BBC, Wuhan, Thomson Locations: Beijing, China, Bengaluru
Austin Ramzy andModerna agrees to sell up to 110 million Covid vaccine doses to African countries. The African Union has ordered 220 million doses of Johnson & Johnson’s single-shot vaccine, with the option to order 180 million more. A shortfall in expected deliveries from Covax this year has left African countries scrambling to come up with alternative plans to vaccinate their populations. Image Waiting for shuttle buses to mandatory government-designated quarantine hotels in the arrival hall at the Hong Kong International Airport in August. Hong Kong has recorded just two locally transmitted cases in the past five months, but Mrs. Lam said the city had still not met Beijing’s standards.
Persons: Zhang Hao, Austin Ramzy, Zohra Bensemra, Moderna, Stéphane Bancel, Biden, Jerome Favre, Europe —, Carrie Lam, Mrs, Lam, Hong, Hong Kong Organizations: Moderna, Union, Associated Press, , Nationwide, Alxa League, Reuters, New York Times, European Union, African Union, African, Johnson, United Nations, Hong Kong International Airport, ., Asia Securities Industry, Financial Markets Association, Hong Locations: Lanzhou, China, Gansu Province, Inner Mongolia, Beijing, Hunan, Hubei, Hainan, Fujian, Dakar, Senegal, Africa, United States, African, Covax, Hong Kong, , Europe, Hong,
The question I am most often asked is about the risk of myocarditis after the vaccine. It occurs very rarely after getting an mRNA Covid-19 vaccine (like the ones made by Moderna and Pfizer) and is more common after the second shot and in young men. First, the risk of developing myocarditis after a Covid-19 infection is much higher than the risk of developing myocarditis after the vaccine. Second, almost all the cases of myocarditis after the vaccine are mild, and people generally get better quickly. Vaccinating my children was an easy choice knowing that the risk of Covid-19 to children is far greater than the risk of the vaccines.
Organizations: Moderna, Pfizer Locations: United States
[You can listen to this episode of “The Ezra Klein Show” on Apple, Spotify, Google or wherever you get your podcasts.] Scientists still don’t fully understand what’s causing long Covid or how to best treat it. But in that sense, long Covid isn’t all that novel. Today, millions of Americans suffer from chronic illnesses set off by the body’s response to infections. And even those who find their conditions identified correctly often struggle to find treatments that work for them.
Persons: , Ezra Klein, , Meghan O’Rourke Organizations: Apple, Spotify, Google Locations: United States, U.S
Covid Cases Keep Falling
  + stars: | 2021-10-26 | by ( David Leonhardt | )   time to read: +2 min
Delta is clearly more contagious, which is the main reason that every metric of the pandemic — cases, hospitalizations and deaths — soared this summer. But a typical Covid case during the Delta wave was about as severe as a typical case during the earlier stages of the pandemic. During the wave in late 2020 and early this year, about 1.2 percent of positive cases led to death; during the Delta wave, the share was 1.1 percent. About 1,500 Americans have died of Covid every day over the past week. Many of them are older and have underlying medical conditions, leaving them vulnerable to severe versions of Covid.
Persons: Dr, Robert Wachter, Wachter Organizations: University of California Locations: San Francisco, U.S
A woman holds a small bottle labelled with a "Coronavirus COVID-19 Vaccine" sticker and a medical syringe in this illustration taken October 30, 2020. REUTERS/Dado Ruvic/File PhotoNEW YORK, Oct 26 (Reuters) - The U.S. Food and Drug Administration is considering authorizing a COVID-19 vaccine for children aged 5 to 11. Here is what you need to know about the vaccine and children:When will COVID-19 vaccines be available for 5- to 11-year-olds? Yes, but at a lower dose. Pfizer and BioNTech said last month their COVID-19 vaccine induced a robust immune response in the 5- to 11-year-olds in its clinical trial.
Persons: Dado, BioNTech, Brittany Kmush, Michael Erman, Richard Chang Organizations: REUTERS, U.S . Food, Drug Administration, Pfizer Inc, FDA, CDC, U.S . Centers for Disease Control, Pfizer, Syracuse University, Moderna Inc, COVID, Thomson Locations: U.S, United States, pediatricians, Brittany
Review of India's Covaxin shot underway, WHO says
  + stars: | 2021-10-26 | by ( )   time to read: +1 min
Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech's COVID-19 vaccine called COVAXIN, during a vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi, India, January 16, 2021. REUTERS/Adnan AbidiGENEVA, Oct 26 (Reuters) - A World Health Organization technical advisory group was reviewing data on India's Covaxin shot against COVID-19 on Tuesday with a decision on its emergency use listing likely soon, a spokesperson said. "If all is in place and all goes well and if the committee is satisfied, we would expect a recommendation within the next 24 hours or so," Margaret Harris told journalists at a U.N. press briefing. Millions of Indians have taken the shot produced by Bharat Biotech but many have been unable to travel pending the WHO approval. read moreReporting by Emma Farge; Editing by Andrew CawthorneOur Standards: The Thomson Reuters Trust Principles.
Persons: Harsh Vardhan, Bharat Biotech's, Adnan Abidi GENEVA, Margaret Harris, Emma Farge, Andrew Cawthorne Organizations: Indian, All India Institute of Medical Sciences, REUTERS, Health, COVID, Bharat Biotech, Thomson Locations: New Delhi, India
Prosecutors say a man from Georgia spent $57,789 in pandemic relief loans on a Pokémon card. The loans were meant to help small businesses cover the economic fallout of the COVID-19 pandemic. The prosecutors accused Vinath Oudomsine of lying to the government about the size of his business. But the filing did reveal what prosecutors allege Oudomsine spent about two-thirds of his relief loan on: a $57,789 Pokémon card, which they said he bought in early January. Collectors and retailers say that scalpers, nostalgia, and YouTube have contributed to the boom in the cards' value.
Persons: Vinath, Oudomsine, Prosecutors, Trump Organizations: Service, Prosecutors, Small Business Administration, Macon Telegraph, Relief, Economic, Court, Southern, Southern District of, SBA, The Washington Post, Target, NFL, MLB, NBA, Collectors, YouTube Locations: Georgia, Dublin , Georgia, Southern District, Southern District of Georgia, Wisconsin
Cruise ships will be allowed to lift COVID-19 restrictions from mid-January, the CDC said Monday. An order imposing restrictions on cruise ships has been in place since last year. An order issued just under a year ago required strict measures for cruise ships sailing in US waters such as 95% vaccination of passengers. The new version includes modifications, like relaxing the necessary levels of vaccination and ceasing to require CDC messaging in the cruise ships' marketing material, The Washington Post reported. The measure will end the travel ban imposed on numerous countries including Brazil, most of Europe, and the UK.
Persons: Biden Organizations: CDC, Service, Washington Post, of Homeland Security Locations: Canada, Mexico, Brazil, Europe
College enrollment was supposed to bounce back this fall. Combined with last autumn's declines, the number of undergraduate students in college is now down 6.5% compared to two years ago — the largest two-year enrollment drop in the last 50 years, the report found. "Far from filling the hole of last year's enrollment declines, we are still digging it deeper." "Community colleges remain the most adversely affected sector, experiencing a 14.1% total enrollment decline since fall 2019." For starters, community college is significantly less expensive.
Persons: Doug Shapiro, Shapiro Organizations: Nationwide, Student Clearinghouse Research, Finance, College Board
Economist David Rosenberg suggests hyperinflation warnings are irrational. According to Rosenberg, it's wrong to assume the impact will cripple the economy and feed into runaway inflation. "People will be surprised as the Fed shifts course and liquidity conditions tighten up. ... We're going to end up having asset deflation, and that's going to filter through into generalized deflation in the economy." "The market has gone up way beyond what should be justified by even strong earnings, and that's because of the Fed," Rosenberg added.
Persons: David Rosenberg, Rosenberg, Jack Dorsey, Merrill Lynch's, he's, Dow Organizations: Rosenberg Research, Twitter, Dow Locations: Covid
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailA top hospital CEO on COVID vaccines for children and employee mandatesDr. Shereef Elnahal, CEO of University Hospital Newark, discusses the key FDA advisory panel meeting today on authorizing Pfizer's COVID vaccine for young children, and why he's mandating a booster shot for employees.
Persons: Shereef Elnahal Organizations: University Hospital Newark
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailWSJ's Zuckerman on how the world rapidly developed a Covid-19 vaccineGreg Zuckerman, Wall Street Journal special writer and investigative reporter, joins 'Squawk Box' to discuss why the Covid-19 vaccines are "modern science's greatest achievement."
Persons: WSJ's Zuckerman, Greg Zuckerman Organizations: Wall Street Journal
The FDA's Vaccines and Related Biological Products Advisory Committee meets Tuesday for an all-day meeting on Pfizer and BioNTech's Covid-19 vaccine for kids ages 5 to 11. Many parents are anxiously awaiting the approval with schools now open across the U.S. and the delta variant driving a surge in children's cases. The meeting starts at 8:30 a.m. ET and is scheduled to wrap up around 5 p.m. with votes on whether to recommend the shots at the end of the day. The FDA is expected to quickly grant emergency approval for the shots before passing the matter on to the CDC for review next week.
Persons: BioNTech's, Biden, it's Organizations: Products, Pfizer, Food and Drug Administration, Centers for Disease Control, FDA, CDC Locations: U.S
A vial labelled with the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine is seen in this illustration picture taken March 19, 2021. REUTERS/Dado RuvicOct 26 (Reuters) - An expert panel will weigh authorization of Pfizer Inc (PFE.N) and BioNTech's COVID-19 vaccine for children aged 5 to 11 on Tuesday as it prepares to vote on a recommendation for the U.S. Food and Drug Administration. Only a few other countries including China, Cuba and the United Arab Emirates have cleared COVID-19 vaccines for children in this age group and younger. FDA staff, in documents posted before the meeting, said the likely vaccine benefits in that age group clearly outweigh the potential harms, including the rare risk of heart inflammation. While children rarely become seriously ill or die from COVID-19, some develop complications, and COVID-19 cases in unvaccinated children have risen due to the contagious Delta variant.
Persons: Dado Ruvic, BioNTech's, Anthony Fauci, Manas Mishra, Caroline Humer, Richard Chang Organizations: Pfizer, REUTERS, Pfizer Inc, U.S . Food, Drug Administration, FDA, United Arab, Moderna, BioNTech, U.S . Centers for Disease Control, CDC, myocarditis, Thomson Locations: United States, China, Cuba, United Arab Emirates, COVID, Bengaluru
A health worker draws Moderna coronavirus disease (COVID-19) vaccine into a syringe inside the COVID-19 Impftram vaccination tram during a media presentation in Zurich, Switzerland September 14, 2021. REUTERS/Arnd Wiegmann/File PhotoBERLIN, Oct 26 (Reuters) - Switzerland said on Tuesday it was recommending COVID-19 booster shots for people over 65 but not for the general population. The recommendation is based on the Swiss medicine regulator's decision to approve booster vaccinations with mRNA vaccines from Pfizer (PFE.N)/Biontech and Moderna (MRNA.O) for high-risk patients, the ministry and EKIF said. For the general population, it is currently not possible and not recommended to get a third vaccination dose based on currently available data, authorities said. They added Switzerland had enough vaccines to offer shots to all patients eligible for booster vaccinations and to all those who have not yet been vaccinated over 2021-2022.
Persons: Arnd, EKIF, Zuzanna, Riham Alkousaa, Nick Macfie Organizations: REUTERS, Pfizer, Moderna, Thomson Locations: Zurich, Switzerland, Swiss
Medical professionals assist coronavirus disease (COVID-19) patients in the overcrowded intensive care unit at the Emergency Hospital "Bagdasar-Arseni", in Bucharest, Romania, October 19, 2021. Daily COVID-19 inoculation numbers have reached pandemic highs this month in the European Union's second-lowest vaccinated country, as Romanians respond to dramatic death rates and newly enforced restrictions. "The COVID-19 (hospital) situation has scared us," she said. I am afraid of side effects which may show up over time, the vaccine has not been sufficiently tested. But in October, more people received their first vaccine shot - just under 1 million out of a total 6.5 million - than over the three months of summer combined, data showed.
Persons: Ganea, Elena Serban, Dumitru Banu, Gabriel Dima, Cristian Radu, Epidemiologist Octavian Jurma, Elena Rosu, Luiza Ilie, Alison Williams Organizations: Emergency, REUTERS, Thomson Locations: Bucharest, Romania, REUTERS BUCHAREST, Europe
CARACAS — Venezuela on Monday reopened public schools and universities which serve more than 11 million students, after a long closure amid the coronavirus pandemic, though some schools remained closed for repairs or because of lack of staff. Youth Minister Mervin Maldonado said 8.7 million children would return to classrooms across the country and some 3.1 million students would resume attending universities. About 40% of the school’s 1,700 registered students returned to classes on Monday, said community representative Pedro Zambrano. Down the road at Caracas’ oldest school, the Andres Bello Educational Complex, Director Wilmer Marcano presided over a mostly empty building. Those age 12 and up in Venezuela are now eligible for their first dose of a Covid-19 vaccine.
Persons: Nicolas Maduro’s, Mervin Maldonado, Jenny Bejarano, Fabian, , Bejarano, Pedro Zambrano, Maria Clemente, Andres Bello, Wilmer Marcano Organizations: Venezuela Experimental Education Unit, Venezuelan Federation of Teachers, Caracas ’, American Health Organization, NBC, Facebook, Twitter Locations: CARACAS — Venezuela, Caracas, Venezuela,
Total: 25